Liver Insufficiency
8
0
0
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
9 treatments under study, led by Hepatocyte Matrix Implant
Research Leaders
10 sponsors active, led by Baylor Research Institute
Related Conditions
Often studied with 20 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 8 trials
100.0%
+13.4% vs benchmark
13%
1 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 6 completed trials
Clinical Trials (8)
An Investigational Study of Experimental Medication BMS-986231 Given in Participants With Different Levels of Liver Function
Liver Function After Intravenous Methylprednisolone Administration
Metabolomics of Liver Regeneration Following Partial Hepatectomy in Healthy Living Liver Donors
A Study of MK0431 in Patients WIth Hepatic Insufficiency (0431-017)(COMPLETED)
Phase 1 Study of Multiple-Dose Pharmacokinetics of Cenicriviroc in Subjects With Mild and Moderate Hepatic Impairment
Quantification of Drugs and Their Degradation Products
Hepatocyte Matrix Implant Study Indonesia
Liver Transplantation and Reticuloendothelial Clearance Capacity
Research Network
Common Treatments
- Hepatocyte Matrix Implant1
- Very High Doses Ivmp Therapy1
- Sitagliptin Phosphate1
- Bms9862311
- Cenicriviroc In Moderate Liver Impaired1
Active Sponsors
- Baylor Research Institute1
- European Society of Organ Transplantation1
- University of Cologne1
- NHS Lothian1
- Baermed1
Top Investigators
Clinical Pharmacology of Miami, Inc.
Medical University of Warsaw
Department of Pharmacology
University of Edinburgh
Baermed, RS Gading Pluit, UNTAR
Related Conditions
- Liver Dysfunction2
- Multiple Organ Failure1
- Heart Decompensation1
- Sepsis1
- Breast Feeding Exclusive1